224 related articles for article (PubMed ID: 31760648)
21. Remyelination in multiple sclerosis.
Brück W; Kuhlmann T; Stadelmann C
J Neurol Sci; 2003 Feb; 206(2):181-5. PubMed ID: 12559508
[TBL] [Abstract][Full Text] [Related]
22. Imaging of remyelination.
Barkhof F
Mult Scler; 1997 Apr; 3(2):129-32. PubMed ID: 9291166
[TBL] [Abstract][Full Text] [Related]
23. Deep learning of joint myelin and T1w MRI features in normal-appearing brain tissue to distinguish between multiple sclerosis patients and healthy controls.
Yoo Y; Tang LYW; Brosch T; Li DKB; Kolind S; Vavasour I; Rauscher A; MacKay AL; Traboulsee A; Tam RC
Neuroimage Clin; 2018; 17():169-178. PubMed ID: 29071211
[TBL] [Abstract][Full Text] [Related]
24. Multiple Sclerosis: Basic and Clinical.
Buzzard K; Chan WH; Kilpatrick T; Murray S
Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
[TBL] [Abstract][Full Text] [Related]
25. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
[TBL] [Abstract][Full Text] [Related]
26. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
27. Multiple sclerosis - remyelination failure as a cause of disease progression.
Hagemeier K; Brück W; Kuhlmann T
Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
[TBL] [Abstract][Full Text] [Related]
28. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
29. Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis.
de Paula Faria D; Real CC; Estessi de Souza L; Teles Garcez A; Navarro Marques FL; Buchpiguel CA
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720130
[TBL] [Abstract][Full Text] [Related]
30. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Zivadinov R
Neurology; 2007 May; 68(22 Suppl 3):S72-82; discussion S91-6. PubMed ID: 17548573
[TBL] [Abstract][Full Text] [Related]
31. Imaging of remyelination and neuronal health.
Erickson BJ
Curr Top Microbiol Immunol; 2008; 318():73-92. PubMed ID: 18219815
[TBL] [Abstract][Full Text] [Related]
32. Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
Lazzarotto A; Hamzaoui M; Tonietto M; Dubessy AL; Khalil M; Pirpamer L; Ropele S; Enzinger C; Battaglini M; Stromillo ML; De Stefano N; Filippi M; Rocca MA; Gallo P; Gasperini C; Stankoff B; Bodini B;
Brain; 2024 Apr; 147(4):1331-1343. PubMed ID: 38267729
[TBL] [Abstract][Full Text] [Related]
33. Quantitative magnetic resonance mapping of the myelin bilayer reflects pathology in multiple sclerosis brain tissue.
Baadsvik EL; Weiger M; Froidevaux R; Faigle W; Ineichen BV; Pruessmann KP
Sci Adv; 2023 Aug; 9(32):eadi0611. PubMed ID: 37566661
[TBL] [Abstract][Full Text] [Related]
34. Immune promotion of central nervous system remyelination.
Rodriguez M; Miller DJ
Prog Brain Res; 1994; 103():343-55. PubMed ID: 7886217
[TBL] [Abstract][Full Text] [Related]
35. Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination.
Staugaitis SM; Chang A; Trapp BD
Acta Neurol Scand Suppl; 2012; (195):97-102. PubMed ID: 23278664
[TBL] [Abstract][Full Text] [Related]
36. A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
Pridham G; Hossain S; Rawji KS; Zhang Y
PLoS One; 2021; 16(4):e0249460. PubMed ID: 33819278
[TBL] [Abstract][Full Text] [Related]
37. Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study.
Lazzarotto A; Tonietto M; Poirion E; Battaglini M; Palladino R; Benoit C; Ricigliano VA; Maillart E; De Stefano N; Stankoff B; Bodini B
Mult Scler; 2022 Oct; 28(12):1881-1890. PubMed ID: 35708126
[TBL] [Abstract][Full Text] [Related]
38. Remyelination in multiple sclerosis: realizing a long-standing challenge.
Aharoni R
Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
[TBL] [Abstract][Full Text] [Related]
39. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
Jadasz JJ; Aigner L; Rivera FJ; Küry P
Cell Tissue Res; 2012 Jul; 349(1):331-47. PubMed ID: 22322424
[TBL] [Abstract][Full Text] [Related]
40. Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis.
Rivera FJ; Aigner L
Biol Res; 2012; 45(3):257-68. PubMed ID: 23283435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
